Caption Management, LLC Pliant Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$10.52 - $14.35 $1.52 Million - $2.07 Million	-144,500 Reduced 82.81%	30,000 $336,000
Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $312,110 - $460,495	29,500 Added 20.34%	174,500 $1.88 Million
Q1 2024 May 15, 2024	BUY	$14.14 - $19.59 $1.63 Million - $2.25 Million	115,000 Added 383.33%	145,000 $2.16 Million
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $543,600 - $916,800	30,000 New	30,000 $543,000
Q2 2022 Aug 15, 2022	BUY	$4.11 - $8.75 $205,500 - $437,500	50,000 New	50,000 $400,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $647M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.